Evaluation of acoustic parameters in patients with laryngopharyngeal reflux.

Evaluation of Acoustic Parameters in Patients with Laryngopharyngeal Reflux-Interventional Study - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070169

Enrollment

Registered

2024-07-08

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00-J06- Acute upper respiratory infections

Interventions

Intervention1: Esomeprazole: Esomeprazole 40 mg BD Per oral for 3 months Control Intervention1: NOT APPLICABLE: NOT APPLICABLE

Eligibility

Inclusion criteria

Inclusion criteria: patients who came with the laryngopharyngeal reflux symptoms are assessed using reflux symptom index were included in the study.reflux symptom index greater than or equal to 13 were taken into study

Exclusion criteria

Exclusion criteria: professional voice users,history of voice abuse,past laryngopharyngeal injuries/uncontrolled endocrine or metabolic problems and biological and neurological diseases affecting the larynx,laryngopharynx or oesophagus.

Design outcomes

Primary

Measure	Time frame
Acoustic voice analysis helps To compare findings in laryngopharyngeal reflux patients before and after antireflux treatment and to prevent laryngopharyngeal reflux complications.Timepoint: outcome will be assessed at zero,first month and third month.	—

Secondary

Measure	Time frame
To reduce voice disorders in laryngopharyngeal reflux patients.Timepoint: outcome will be assessed at zero first third month	—

Countries

India

Contacts

Public ContactVishnusankar T G

SRMMCH and RC Kaatankulathur campus

crk_balaji@yahoo.co.in9884187257

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026